The Pharmaceutical giant say they are taking steps to resolve a multi-billion dollar cancer-related lawsuit with thousands of ...
Johnson & Johnson announced Wednesday that it plans to pay nearly $6.5 billion over 25 years to settle all pending and future ...
May 1 (UPI) --Pharmaceutical giant Johnson & Johnson on Wednesday said it is taking steps to resolve a multibillion dollar, cancer-related lawsuit with thousands of individuals over claims that ...
Johnson & Johnson on Wednesday proposed a plan to pay nearly $6.5 billion to resolve tens of thousands of lawsuits claiming that its cosmetic talc-based powder causes cancer. Through a ...
Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news ...
Johnson and Johnson reiterated in its statement on Wednesday, May 1, that “none of the talc-related claims against it have merit” Charna Flam is a writer-reporter at PEOPLE. She has been ...
The offer is the company’s third attempt to resolve tens of thousands of claims that its baby powder caused ovarian cancer and mesothelioma.
Johnson & Johnson has allocated a reserve totaling $11 billion to accommodate talc-related settlements. The proposed settlement aims to address the majority of talc-related litigation regarding ...
Johnson & Johnson is proposing a $6.5 billion settlement to resolve thousands of lawsuits claiming its talc products caused ovarian cancer. J&J aims to settle the legal claims through a third ...
Benzinga - by Vandana Singh, Benzinga Editor. Wednesday, Johnson & Johnson (NYSE:JNJ) announced its intention to proceed with a $6.475 billion settlement to resolve numerous lawsuits related to ...